Improved Voriconazole Topical Delivery by Nanoparticles (Minireview)
- Autores: Nassiri-Kashani M.1, Namdar R.2,3, Nafisi S.2,3, Maibach H.I.3
- 
							Afiliações: 
							- Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences
- Department of Chemistry, Central Tehran Branch
- Department of Dermatology, University of California
 
- Edição: Volume 50, Nº 2 (2016)
- Páginas: 76-79
- Seção: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244322
- DOI: https://doi.org/10.1007/s11094-016-1401-6
- ID: 244322
Citar
Resumo
Voriconazole is a triazole antifungal drug used to treat invasive fungal infections including candidiasis, aspergillosis, and certain emerging fungal infections. Voriconazole demonstrates low water solubility. Therefore, drug solubilization is necessary for effective topical delivery. Nano-strategy may overcome its poor aqueous solubility as well as controlled drug release at action site, reduction of total dose, avoidance of systemic absorption and dosage form retention on skin. In topical antifungal administration, drug should pass outermost layer of skin; stratum corneum to reach lower layers, particularly into follicular epithelium. Nano-formulations including colloidal systems, vesicular carriers, and nanoparticles may play a major role for enhancing antifungals permeation profile. Present review surveys key experiments with voriconazole nano-based formulations used in superficial fungal infections treatment.
Palavras-chave
Sobre autores
Mansour Nassiri-Kashani
Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences
														Email: maibachh@derm.ucsf.edu
				                					                																			                												                	Irã, 							Tehran						
Roshanak Namdar
Department of Chemistry, Central Tehran Branch; Department of Dermatology, University of California
														Email: maibachh@derm.ucsf.edu
				                					                																			                												                	Irã, 							Tehran, IAU; San Francisco, CA						
Shohreh Nafisi
Department of Chemistry, Central Tehran Branch; Department of Dermatology, University of California
							Autor responsável pela correspondência
							Email: drshnafisi@gmail.com
				                					                																			                												                	Irã, 							Tehran, IAU; San Francisco, CA						
Howard Maibach
Department of Dermatology, University of California
							Autor responsável pela correspondência
							Email: maibachh@derm.ucsf.edu
				                					                																			                												                	Estados Unidos da América, 							San Francisco, CA						
Arquivos suplementares
 
				
			 
						 
						 
						 
						 
					 
				 
  
  
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail  Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Somente assinantes
		                                		                                        Somente assinantes
		                                					